Developing Cryosuit - usability and performance validation of our portable, rapid cooling device for heat-related illness.
Developing Cryosuit - usability and performance validation of our portable, rapid cooling device for heat-related illness.
批准号:
10035497
负责人:
金额:
$27.7万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --
中文摘要
**开发冷冻服-我们便携式快速冷却设备的可用性和性能验证,用于热相关疾病。**高温引起的疾病和并发症对全世界的人口健康和经济产生重大影响。中暑会造成重要器官损伤,如果不及时进行降低核心体温的治疗,会导致严重的衰弱或死亡。与热有关的疾病(HRI),如中暑,在2000年至2009年期间花费了英国38.5亿英镑\[CCC.org-2019\]。到2030年,热应激将使全球经济每年损失1.8万亿英镑的生产力和医疗保健\[UN,2019\]。因此,全球变暖和极端天气模式日益频繁,迫切需要新技术来治疗HRI。2018年环境审计委员会的一份报告预测,如果没有政府干预,英国“到2050年,与热有关的死亡人数将增加两倍”。Cryogenx的目标是通过Cryosuit从根本上颠覆价值3.6亿英镑的“冷疗法”热病治疗市场;我们的便携式快速冷却装置,用于现场处理HRI。它结构紧凑,自供电,重量轻,易于操作,可以有效地部署在任何场景中,克服了当前冷却方法的后勤障碍和资源依赖。至关重要的是,Cryosuit将使救生冷却尽快启动;影响患者预后的最大单一因素。基于我们最初的冷冻服原型-初步测试数据显示冷却速度快2.5倍,持续时间3倍,70% reduction in cost compared to existing field HRI treatment methods - this experimental development project will optimise the technology to demonstrate the usability, safety and efficacy required to be a recognised healthcare solution.With support form University Hospitals Birmingham NHS Foundation Trust, we'll develop our technology via human-centred-design principles into a full-scale V2 prototype, validated in field-trials with Brunel University, Air Ambulance, Balfour Beatty and UK Special Forces.The projects outputs will be:* Ergonomically designed TRL6 prototype and packaging with integrated gas delivery system* Clinical datasets and validation from end-user field trials
英文摘要
**Developing the Cryosuit - usability and performance validation of our portable, rapid cooling device for heat-related illness.**Illness and complications brought on by heat has a significant impact on population health and economies worldwide. Heatstroke causes vital organ damage, leading to serious debilitation or death, if treatment to lower core body temperature is not administered quickly.Heat-related illnesses(HRI) such as heat stroke cost the UK £3.85bn between 2000-2009 \[CCC.org-2019\]. By 2030, heat stress will cost the global economy £1.8 trillion/year in lost productivity and healthcare\[UN,2019\].Global warming and the increasing regularity of extreme weather patterns is therefore driving an urgent need for new technologies to treat HRI, with a 2018 Environmental Audit Committee report predicting "heat-related deaths are set to treble by 2050" in the UK without Government intervention.Cryogenx aims to radically disrupt the £360m 'cold therapy' heat illness treatment market with Cryosuit; our portable rapid cooling device for treating HRI in-the-field. Compact, self-powered and lightweight, it's easy to operate and can be effectively deployed in any scenario, overcoming the logistical barriers and resource dependency of current cooling methods.Critically, Cryosuit will enable life-saving cooling to be initiated as rapidly as possible; the single largest factor influencing patient outcome.Building on our initial Cryosuit prototype - which data from preliminary tests shows to have 2.5x faster cooling rate, 3x duration, and 70% reduction in cost compared to existing field HRI treatment methods - this experimental development project will optimise the technology to demonstrate the usability, safety and efficacy required to be a recognised healthcare solution.With support form University Hospitals Birmingham NHS Foundation Trust, we'll develop our technology via human-centred-design principles into a full-scale V2 prototype, validated in field-trials with Brunel University, Air Ambulance, Balfour Beatty and UK Special Forces.The projects outputs will be:* Ergonomically designed TRL6 prototype and packaging with integrated gas delivery system* Clinical datasets and validation from end-user field trials
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金